BEUDAMED
    FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

    Coronary Drug-Eluting Stent

    PMA: P060033 · Supplement: S017 · Decision Nov 19, 2008
    View on FDA
    Classifications
    1
    FEI Numbers
    32
    Registration Numbers
    32

    Basic Information

    Device Name
    Coronary Drug-Eluting Stent
    Trade Name
    ENDEAVOR SPRINT ZOTAROLIMUS-ELUTING CORONARY STENT SYSTEM
    PMA Number
    P060033
    Supplement Number
    S017
    Device Class
    FDA Class 3
    Product Code
    NIQ
    Generic Name
    Coronary drug-eluting stent
    Medical Specialty
    Unknown
    Advisory Committee
    Cardiovascular
    Decision
    30-Day Notice Accepted
    Decision Code
    OK30
    Decision Date
    November 19, 2008
    Date Received
    October 20, 2008
    Supplement Type
    30-Day Notice
    Supplement Reason
    Process Change - Manufacturer/Sterilizer/Packager/Supplier
    Expedited Review
    N

    Advisory Committee Statement

    CHANGES TO THE ENDEAVOR SPRINT ZOTAROLIMUS-ELUTING CORONARY STENT SYSTEM: 1) REUSE OF CATHETER HOOPS; 2) ELIMINATE PRE-PC SPRAY INSPECTION WORK STEP; 3) WELDING PROCESS AUTOMATION; 4) ALTERNATIVE POUCH SEALING EQUIPMENT; 5) CHANGE TO STENT STORAGE AND TRANSPORTATION VIAL; AND 6) CONICAL SPRAY JAR ASSEMBLY.

    Classifications

    This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

    Product Code Device Name
    NIQ Coronary Drug-Eluting Stent